Concepedia

Beodeul Kang

BK

Statistics

Publications

57

Citations

2.2K

H-Index

28

Active since

2012

Affiliations

CHA University Bundang Medical Center(Current)

Yonsei University

Seoul National University Bundang Hospital

Beodeul Kang is an author at CHA University Bundang Medical Center specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2012–2025

57

Publications

57

Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma

Chang Gon Kim, Chan Kim, Sang Eun Yoon et al. · Journal of Hepatology · 2020 · 192 citations · Full text

Medicine, Cancer Biology, Oncology +16

Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis

Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima et al. · ESMO Open · 2022 · 130 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer refractory to gemcitabine and cisplatin: a multi-institutional phase 2 trial of the Korean Cancer Study Group (KCSG-HB19–14)

Choong‐kun Lee, Hong Jae Chon, Jaekyung Cheon et al. · The Lancet. Gastroenterology & hepatology · 2022 · 124 citations · Full text

Medicine, Oncology, Pharmacology +12

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

Seung Joon Lee, Hannah Yang, Woo Ram Kim et al. · Journal for ImmunoTherapy of Cancer · 2021 · 123 citations · Full text

Medicine, Immunology, Oncology +17

Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death‐Ligand 1 Blockade Responses

Jihoon G. Yoon, Min Hwan Kim, Mi Jang et al. · Hepatology · 2021 · 92 citations · Full text

Medicine, Oncology, Pathology +17

1–5 of 57